Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers

This study has been completed.
Information provided by (Responsible Party):
CytoDyn, Inc. Identifier:
First received: May 10, 2005
Last updated: December 14, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)